CERO
CERo Therapeutics Holdings, Inc.
Price Chart
Latest Quote
$0.01
+0.00 (+0.00%)
Current Price
| Previous Close | $0.01 |
| Open | $0.01 |
| Day High | $0.01 |
| Day Low | $0.01 |
| Volume | 64,697 |
Stock Information
| Shares Outstanding | 45.11M |
| Total Debt | $598K |
| Cash Equivalents | $857K |
| Net Income | $-95.96M |
| Sector | Healthcare |
| Industry | Biotechnology |
| Market Cap | $541K |
| P/E Ratio | 0.00 |
| EPS (TTM) | $9.04 |
| Exchange | OQB |
đ Comprehensive Analysis
Company Data
| Enterprise Value | $7.49M |
| Income | $-95.96M |
| Book/sh | $-0.46 |
| Cash/sh | $0.02 |
| Employees | 8 |
Financial Ratios
| Quick Ratio | 0.08 |
| Current Ratio | 0.14 |
Returns & Margins
| ROA | -241.15% |
Ownership
| Insider Ownership | 4.13% |
| Institutional Ownership | 0.14% |
| Insider & Institutional transactions data not available | |
Valuation Ratios
| Forward P/E | -0.00 |
| P/B | -0.03 |
Analyst Data
| Recommendation | none |
Technical Indicators
| SMA20 | $0.02 |
| SMA50 | $0.02 |
| SMA200 | $0.97 |
| RSI | 33.33 |
| ATR | 0.0046 |
| Shares Float | 43.14M |
| Short Float | 10.50% |
| Short Ratio | 0.83 |
| Rel Volume | 0.06 |
Performance History
| Week | -14.29% |
| Month | -55.56% |
| Quarter | -63.64% |
| 6 Months | -86.81% |
| YTD | -82.09% |
| Year | -99.83% |
| 3 Years | -100.00% |
| 10 Years | -100.00% |
Stock Score:
â Premium
Based on debt, profitability, growth, and cash flow metrics
â Premium Feature
Sign up for free to view detailed scoring breakdown â premium is free during our trial period!
Recent Price History
| Date | Close | Volume |
|---|---|---|
| 2026-06-17 | $0.01 | 64,697 |
| 2026-06-16 | $0.01 | 973,900 |
| 2026-06-15 | $0.01 | 2,258,400 |
| 2026-06-12 | $0.01 | 552,600 |
| 2026-06-11 | $0.01 | 423,400 |
| 2026-06-10 | $0.01 | 1,288,300 |
| 2026-06-09 | $0.01 | 1,138,000 |
| 2026-06-08 | $0.01 | 487,000 |
| 2026-06-05 | $0.01 | 1,395,000 |
| 2026-06-04 | $0.01 | 1,959,200 |
| 2026-06-03 | $0.01 | 810,500 |
| 2026-06-02 | $0.01 | 2,055,100 |
| 2026-06-01 | $0.01 | 2,687,900 |
| 2026-05-29 | $0.02 | 1,036,900 |
| 2026-05-28 | $0.02 | 399,100 |
| 2026-05-27 | $0.02 | 528,800 |
| 2026-05-26 | $0.02 | 2,047,400 |
| 2026-05-22 | $0.02 | 211,000 |
| 2026-05-21 | $0.02 | 669,300 |
| 2026-05-20 | $0.02 | 456,300 |
| 2026-05-19 | $0.02 | 2,722,800 |
| 2026-05-18 | $0.03 | 598,000 |
About CERo Therapeutics Holdings, Inc.
CERo Therapeutics Holdings, Inc., an immunotherapy company, engages in the development of engineered T cell therapeutics for the treatment of cancer. The company's lead development candidate is CER-1236, an autologous T cell therapy candidate for the treatment of hematologic malignancies and solid tumors. The company was incorporated in 2021 and is based in South San Francisco, California.
Period:
Loading...
Income Statement (Annual)
| Metric | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|
| Revenue | |||
| Total Revenue | $0 | $0 | $0 |
| Operating Revenue | $0 | $0 | $0 |
| Expenses | |||
| Total Expenses | $7,675,049 | $11,971,231 | $11,616,331 |
| Other Income Expense | $247,132 | - | - |
| Other Non Operating Income Expenses | $-62,182 | - | - |
| Net Non Operating Interest Income Expense | $138,340 | $142,115 | $986,711 |
| Operating Expense | $7,675,049 | $11,971,231 | $11,616,331 |
| General And Administrative Expense | $2,386,469 | $2,125,628 | $2,479,447 |
| Income & Earnings | |||
| Net Income From Continuing Operation Net Minority Interest | $-7,289,577 | $-11,829,116 | $-10,629,620 |
| Net Interest Income | $138,340 | $142,115 | $986,711 |
| Interest Income | $138,340 | $142,115 | $986,711 |
| Normalized Income | $-7,598,891 | $-11,829,116 | $-10,629,620 |
| Net Income From Continuing And Discontinued Operation | $-7,289,577 | $-11,829,116 | $-10,629,620 |
| Total Operating Income As Reported | $-7,675,049 | $-11,971,231 | $-11,616,331 |
| Net Income Common Stockholders | $-7,289,577 | $-11,829,116 | $-10,629,620 |
| Net Income | $-7,289,577 | $-11,829,116 | $-10,629,620 |
| Net Income Including Noncontrolling Interests | $-7,289,577 | $-11,829,116 | $-10,629,620 |
| Net Income Continuous Operations | $-7,289,577 | $-11,829,116 | $-10,629,620 |
| Pretax Income | $-7,289,577 | $-11,829,116 | $-10,629,620 |
| Special Income Charges | $8,144 | - | - |
| Interest Income Non Operating | $138,340 | $142,115 | $986,711 |
| Operating Income | $-7,675,049 | $-11,971,231 | $-11,616,331 |
| Per Share | |||
| Diluted EPS | $-1416.55 | $-2610.71 | $-2345.98 |
| Basic EPS | $-1416.55 | $-2610.71 | $-2345.98 |
| Other | |||
| Tax Effect Of Unusual Items | $0 | $0 | $0 |
| Tax Rate For Calcs | $0 | $0 | $0 |
| Normalized EBITDA (Bullshit earnings) | $-6,867,165 | $-10,898,422 | $-10,880,858 |
| Total Unusual Items | $309,314 | - | - |
| Total Unusual Items Excluding Goodwill | $309,314 | - | - |
| Reconciled Depreciation | $1,117,198 | $1,072,809 | $735,473 |
| EBITDA (Bullshit earnings) | $-6,557,851 | $-10,898,422 | $-10,880,858 |
| EBIT | $-7,675,049 | $-11,971,231 | $-11,616,331 |
| Diluted Average Shares | $5,964 | $4,531 | $4,531 |
| Basic Average Shares | $5,964 | $4,531 | $4,531 |
| Diluted NI Availto Com Stockholders | $-7,289,577 | $-11,829,116 | $-10,629,620 |
| Otherunder Preferred Stock Dividend | $0 | - | - |
| Other Special Charges | $-8,144 | - | - |
| Gain On Sale Of Security | $301,170 | - | - |
| Research And Development | $5,288,580 | $9,845,603 | $9,136,884 |
| Selling General And Administration | $2,386,469 | $2,125,628 | $2,479,447 |
| Other Gand A | $2,386,469 | $2,125,628 | $2,479,447 |
Fetched: 2026-02-02
Balance Sheet (Annual)
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Assets | ||||
| Net Tangible Assets | $-1,894,563 | $-42,057,695 | $-34,870,780 | $-23,428,359 |
| Total Assets | $6,206,929 | $5,126,302 | $11,349,488 | $24,175,570 |
| Total Non Current Assets | $2,492,888 | $3,156,267 | $4,273,465 | $4,652,043 |
| Non Current Deferred Assets | $500,000 | $0 | - | - |
| Current Assets | $3,714,041 | $1,970,035 | $7,076,023 | $19,523,528 |
| Other Current Assets | $274,749 | $368,780 | $256,459 | $306,046 |
| Current Deferred Assets | $112,232 | $0 | - | - |
| Cash Cash Equivalents And Short Term Investments | $3,327,060 | $1,601,255 | $6,819,564 | $19,217,482 |
| Cash And Cash Equivalents | $3,327,060 | $1,601,255 | $6,819,564 | $19,217,482 |
| Cash Financial | $3,327,060 | $1,601,255 | $6,819,564 | $19,217,482 |
| Debt | ||||
| Total Debt | $1,575,499 | $2,944,283 | $3,016,964 | $3,602,214 |
| Long Term Debt And Capital Lease Obligation | $699,107 | $1,575,499 | $2,344,590 | $3,016,964 |
| Current Debt And Capital Lease Obligation | $876,392 | $1,368,784 | $672,374 | $585,250 |
| Current Debt | - | $599,692 | - | - |
| Liabilities | ||||
| Total Liabilities Net Minority Interest | $8,101,492 | $47,183,997 | $46,220,268 | $47,603,929 |
| Total Non Current Liabilities Net Minority Interest | $699,107 | $43,676,843 | $45,056,315 | $45,765,681 |
| Current Liabilities | $7,402,385 | $3,507,154 | $1,163,953 | $1,838,248 |
| Other Current Liabilities | $20,000 | $321,992 | - | - |
| Current Notes Payable | $0 | $599,692 | - | - |
| Payables And Accrued Expenses | $6,261,691 | $1,747,681 | $471,821 | $488,695 |
| Interest Payable | $0 | $27,637 | - | - |
| Payables | $4,671,266 | $1,671,745 | $391,185 | $459,919 |
| Dividends Payable | $85,500 | $0 | - | - |
| Total Tax Payable | $78,448 | $0 | - | - |
| Accounts Payable | $4,507,318 | $1,671,745 | $391,185 | $459,919 |
| Derivative Product Liabilities | - | - | $610,381 | $647,373 |
| Equity | ||||
| Common Stock Equity | $-5,071,009 | $-42,057,695 | $-34,870,780 | $-23,428,359 |
| Preferred Stock Equity | $3,176,446 | - | - | - |
| Total Equity Gross Minority Interest | $-1,894,563 | $-42,057,695 | $-34,870,780 | $-23,428,359 |
| Stockholders Equity | $-1,894,563 | $-42,057,695 | $-34,870,780 | $-23,428,359 |
| Other Equity Interest | $-1,295,444 | - | - | - |
| Retained Earnings | $-70,917,853 | $-43,089,821 | $-35,800,244 | $-23,971,128 |
| Preferred Securities Outside Stock Equity | $0 | $42,101,344 | $42,101,344 | $42,101,344 |
| Other | ||||
| Ordinary Shares Number | $137,940 | $5,964 | $5,146 | $5,146 |
| Share Issued | $137,940 | $5,964 | $5,146 | $5,146 |
| Tangible Book Value | $-5,071,009 | $-42,057,695 | $-34,870,780 | $-23,428,359 |
| Invested Capital | $-5,071,009 | $-41,458,003 | $-34,870,780 | $-23,428,359 |
| Working Capital | $-3,688,344 | $-1,537,119 | $5,912,070 | $17,685,280 |
| Capital Lease Obligations | $1,575,499 | $2,344,591 | $3,016,964 | $3,602,214 |
| Total Capitalization | $-1,894,563 | $-42,057,695 | $-34,870,780 | $-23,428,359 |
| Additional Paid In Capital | $67,142,046 | $1,032,125 | $928,560 | $541,872 |
| Capital Stock | $3,176,688 | $1 | $904 | $897 |
| Common Stock | $242 | $1 | $904 | $897 |
| Preferred Stock | $3,176,446 | $0 | - | - |
| Long Term Capital Lease Obligation | $699,107 | $1,575,499 | $2,344,590 | $3,016,964 |
| Current Capital Lease Obligation | $876,392 | $769,092 | $672,374 | $585,250 |
| Pensionand Other Post Retirement Benefit Plans Current | $244,302 | $68,697 | $19,758 | $764,303 |
| Current Accrued Expenses | $1,590,425 | $75,936 | $80,636 | $28,776 |
| Net PPE | $1,992,888 | $3,156,267 | $4,273,465 | $4,652,043 |
| Accumulated Depreciation | $-2,026,070 | $-1,587,889 | $-1,127,167 | $-650,892 |
| Gross PPE | $4,018,958 | $4,744,156 | $5,400,632 | $5,302,935 |
| Other Properties | $3,972,206 | $4,697,404 | $5,353,880 | $5,276,238 |
| Machinery Furniture Equipment | $46,752 | $46,752 | $46,752 | $26,697 |
| Buildings And Improvements | - | - | $2,846,041 | $3,442,575 |
| Properties | - | - | $0 | $0 |
Fetched: 2026-02-02
Cash Flow Statement (Annual)
| Metric | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|
| Free Cash Flow | |||
| Free Cash Flow | $-5,789,987 | $-12,403,543 | $-10,706,946 |
| Operating Activities | |||
| Operating Cash Flow | $-5,789,987 | $-11,709,311 | $-10,094,380 |
| Cash Flow From Continuing Operating Activities | $-5,789,987 | $-11,709,311 | $-10,094,380 |
| Operating Gains Losses | $-290,264 | $-36,992 | $-980,308 |
| Investing Activities | |||
| Capital Expenditure | - | $-694,232 | $-612,566 |
| Investing Cash Flow | - | $-694,232 | $-612,566 |
| Cash Flow From Continuing Investing Activities | - | $-694,232 | $-612,566 |
| Financing Activities | |||
| Issuance Of Capital Stock | $0 | - | - |
| Financing Cash Flow | $571,678 | $5,625 | $60,255 |
| Cash Flow From Continuing Financing Activities | $571,678 | $5,625 | $60,255 |
| Net Other Financing Charges | $-39,318 | - | - |
| Net Preferred Stock Issuance | $0 | - | - |
| Preferred Stock Issuance | $0 | - | - |
| Other | |||
| Issuance Of Debt | $605,230 | - | - |
| End Cash Position | $1,601,255 | $6,819,564 | $19,217,482 |
| Beginning Cash Position | $6,819,564 | $19,217,482 | $29,864,173 |
| Changes In Cash | $-5,218,309 | $-12,397,918 | $-10,646,691 |
| Proceeds From Stock Option Exercised | $5,766 | $5,625 | $60,255 |
| Net Issuance Payments Of Debt | $605,230 | - | - |
| Net Short Term Debt Issuance | $0 | - | - |
| Short Term Debt Issuance | $0 | - | - |
| Net Long Term Debt Issuance | $605,230 | - | - |
| Long Term Debt Issuance | $605,230 | - | - |
| Change In Working Capital | $540,105 | $-1,297,082 | $492,340 |
| Change In Other Current Liabilities | $-672,373 | $-585,250 | $-294,650 |
| Change In Payables And Accrued Expense | $1,324,799 | $-761,419 | $689,264 |
| Change In Accrued Expense | $44,239 | $-692,685 | $477,090 |
| Change In Payable | $1,280,560 | $-68,734 | $212,174 |
| Change In Account Payable | $1,280,560 | $-68,734 | $212,174 |
| Change In Prepaid Assets | $-112,321 | $49,587 | $97,726 |
| Other Non Cash Items | $35,655 | - | - |
| Stock Based Compensation | $96,896 | $381,070 | $287,735 |
| Depreciation Amortization Depletion | $1,117,198 | $1,072,809 | $735,473 |
| Depreciation And Amortization | $1,117,198 | $1,072,809 | $735,473 |
| Depreciation | $1,117,198 | $1,072,809 | $735,473 |
| Gain Loss On Investment Securities | $-290,264 | $-36,992 | $-980,308 |
| Net Income From Continuing Operations | $-7,289,577 | $-11,829,116 | $-10,629,620 |
| Net PPE Purchase And Sale | - | $-694,232 | $-612,566 |
| Purchase Of PPE | - | $-694,232 | $-612,566 |
Fetched: 2026-02-02